Gene augmentation and read-through rescue channelopathy in an iPSC-RPE model of congenital blindness

Purpose Mutations in the KCNJ13 gene are known to cause Leber’s Congenital Amaurosis (LCA16), an inherited pediatric blindness. KCNJ13 gene encodes the Kir7.1 subunit protein which acts as a tetrameric inwardly rectifying potassium ion channel in the retinal pigment epithelium to maintain ionic homeostasis thereby allowing photoreceptors to encode visual information. We sought to determine if genetic approaches might be effective in treating blindness due to mutations in KCNJ13. Methods We developed patient-derived hiPSC-RPE carrying an autosomal recessive nonsense mutation in the KCNJ13 gene (c.158G>A, p.Trp53*). We performed biochemical and electrophysiology assays of Kir7.1 function. Both small molecule read-through drug and gene-therapy approaches were tested using this disease-in-a-dish approach. Results We found that the LCA16 hiPSC-RPE had normal morphology but did not express a functional Kir7.1 channel and was unable to demonstrate normal physiology. Following read-through drug treatment, the LCA16 hiPSC cells were hyperpolarized by 30 mV and Kir7.1 current was restored. Similarly, loss-of-function of Kir7.1 channel was circumvented by lentiviral gene delivery to the hiPSC-RPE cells. In either approach, Kir7.1 protein was expressing normally with restoration of membrane potential and Kir7.1 current. Conclusion Loss-of-function mutation in Kir7.1 is a cause of LCA. Using either read-through therapy or gene augmentation, we rescued Kir7.1 channel function in patient-derived iPSC-RPE cells via a precision medicine approach.

[1]  G. Mardon,et al.  Conditional loss of Kcnj13 in the retinal pigment epithelium causes photoreceptor degeneration , 2018, Experimental eye research.

[2]  A. V. Cideciyan,et al.  BEST1 gene therapy corrects a diffuse retina-wide microdetachment modulated by light exposure , 2018, Proceedings of the National Academy of Sciences.

[3]  Nathan A Hotaling,et al.  Primary Cilium-Mediated Retinal Pigment Epithelium Maturation Is Disrupted in Ciliopathy Patient Cells , 2018, Cell reports.

[4]  R. Ali,et al.  The Future Looks Brighter After 25 Years of Retinal Gene Therapy. , 2017, Human gene therapy.

[5]  T. V. van Veen,et al.  The immature electrophysiological phenotype of iPSC‐CMs still hampers in vitro drug screening: Special focus on IK1 , 2017, Pharmacology & therapeutics.

[6]  B. Lorenz,et al.  Evaluation of tolerance to lentiviral LV‐RPE65 gene therapy vector after subretinal delivery in non‐human primates , 2017, Translational research : the journal of laboratory and clinical medicine.

[7]  P. Shahi,et al.  Abnormal Electroretinogram after Kir7.1 Channel Suppression Suggests Role in Retinal Electrophysiology , 2017, Scientific Reports.

[8]  R. Whittaker,et al.  A Guide to Approaching Regulatory Considerations for Lentiviral-Mediated Gene Therapies , 2017, Human gene therapy methods.

[9]  K. Airenne,et al.  Comparative Study of Adeno-associated Virus, Adenovirus, Bacu lovirus and Lentivirus Vectors for Gene Therapy of the Eyes. , 2017, Current gene therapy.

[10]  J. Bennett.  Taking Stock of Retinal Gene Therapy: Looking Back and Moving Forward. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[11]  L. da Cruz,et al.  Rescue of the MERTK phagocytic defect in a human iPSC disease model using translational read-through inducing drugs , 2017, Scientific Reports.

[12]  Kathleen A. Marshall,et al.  Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial , 2016, The Lancet.

[13]  J. Sahel,et al.  Let There Be Light: Gene and Cell Therapy for Blindness. , 2016, Human gene therapy.

[14]  Zhe Zhang,et al.  Cleft Palate, Moderate Lung Developmental Retardation and Early Postnatal Lethality in Mice Deficient in the Kir7.1 Inwardly Rectifying K+ Channel , 2015, PloS one.

[15]  E. Traboulsi,et al.  A Novel KCNJ13 Nonsense Mutation and Loss of Kir7.1 Channel Function Causes Leber Congenital Amaurosis (LCA16) , 2015, Human mutation.

[16]  G. Mardon,et al.  CRISPR-engineered mosaicism rapidly reveals that loss of Kcnj13 function in mice mimics human disease phenotypes , 2015, Scientific Reports.

[17]  I. Bird,et al.  Oxytocin expression and function in the posterior retina: a novel signaling pathway. , 2015, Investigative ophthalmology & visual science.

[18]  H. Bolz,et al.  A Distinct Vitreo-retinal Dystrophy with Early-onset Cataract from Recessive KCNJ13 Mutations , 2015, Ophthalmic genetics.

[19]  E. Nandrot,et al.  Large-scale purification of porcine or bovine photoreceptor outer segments for phagocytosis assays on retinal pigment epithelial cells. , 2014, Journal of visualized experiments : JoVE.

[20]  J. Thomson,et al.  Loss of MITF expression during human embryonic stem cell differentiation disrupts retinal pigment epithelium development and optic vesicle cell proliferation. , 2014, Human molecular genetics.

[21]  R. Cone,et al.  G-protein independent coupling of the MC4R to Kir 7.1 in hypothalamic neurons , 2014, Nature.

[22]  B. Pattnaik,et al.  Focus on Kir7.1: physiology and channelopathy , 2014, Channels.

[23]  U. Wolfrum,et al.  Translational read-through of the RP2 Arg120stop mutation in patient iPSC-derived retinal pigment epithelium cells , 2014, Human molecular genetics.

[24]  D. Rand,et al.  The inwardly rectifying K+ channel KIR7.1 controls uterine excitability throughout pregnancy , 2014, EMBO molecular medicine.

[25]  J. Schacht,et al.  Designer Aminoglycosides That Selectively Inhibit Cytoplasmic Rather than Mitochondrial Ribosomes Show Decreased Ototoxicity , 2013, The Journal of Biological Chemistry.

[26]  E. Capowski,et al.  Functional analysis of serially expanded human iPS cell-derived RPE cultures. , 2013, Investigative ophthalmology & visual science.

[27]  G. Fishman,et al.  iPS cell modeling of Best disease: insights into the pathophysiology of an inherited macular degeneration. , 2013, Human molecular genetics.

[28]  U. Wolfrum,et al.  A comparative evaluation of NB30, NB54 and PTC124 in translational read-through efficacy for treatment of an USH1C nonsense mutation , 2012, EMBO molecular medicine.

[29]  E. Percin,et al.  Blood-derived human iPS cells generate optic vesicle-like structures with the capacity to form retinal laminae and develop synapses. , 2012, Investigative ophthalmology & visual science.

[30]  V. Plagnol,et al.  Recessive mutations in KCNJ13, encoding an inwardly rectifying potassium channel subunit, cause leber congenital amaurosis. , 2011, American journal of human genetics.

[31]  U. Wolfrum,et al.  PTC124-mediated translational readthrough of a nonsense mutation causing Usher syndrome type 1C. , 2011, Human gene therapy.

[32]  V. Belakhov,et al.  Repairing faulty genes by aminoglycosides: development of new derivatives of geneticin (G418) with enhanced suppression of diseases-causing nonsense mutations. , 2010, Bioorganic & medicinal chemistry.

[33]  A. Edwards,et al.  Kir7.1 Channel Mutation (R162W), Associated With Snowflake Vitreoretinal Degeneration (SVD), Results in a Non-Functional Channel , 2010 .

[34]  Su-Chun Zhang,et al.  Modeling early retinal development with human embryonic and induced pluripotent stem cells , 2009, Proceedings of the National Academy of Sciences.

[35]  D. Bedwell,et al.  Poly-l-aspartic Acid Enhances and Prolongs Gentamicin-mediated Suppression of the CFTR-G542X Mutation in a Cystic Fibrosis Mouse Model* , 2009, Journal of Biological Chemistry.

[36]  Matthew Mort,et al.  A meta‐analysis of nonsense mutations causing human genetic disease , 2008, Human mutation.

[37]  A. Edwards,et al.  Mutations in KCNJ13 cause autosomal-dominant snowflake vitreoretinal degeneration. , 2008, American journal of human genetics.

[38]  Hua Fan-Minogue,et al.  Eukaryotic ribosomal RNA determinants of aminoglycoside resistance and their role in translational fidelity. , 2007, RNA.

[39]  M. Porteus,et al.  A Look to Future Directions in Gene Therapy Research for Monogenic Diseases , 2006, PLoS genetics.

[40]  S. E. Barker,et al.  Effective gene therapy with nonintegrating lentiviral vectors , 2006, Nature Medicine.

[41]  B. Hughes,et al.  Expression and localization of the inwardly rectifying potassium channel Kir7.1 in native bovine retinal pigment epithelium. , 2003, Investigative ophthalmology & visual science.

[42]  P. Campochiaro,et al.  Expression and permeation properties of the K+ channel Kir7.1 in the retinal pigment epithelium , 2001, The Journal of physiology.

[43]  T. Pape,et al.  Conformational switch in the decoding region of 16S rRNA during aminoacyl-tRNA selection on the ribosome , 2000, Nature Structural Biology.

[44]  K. Grzeschik,et al.  Partial gene structure and assignment to chromosome 2q37 of the human inwardly rectifying K+ channel (Kir7.1) gene (KCNJ13). , 1998, Genomics.

[45]  D. Clapham,et al.  A Novel Inward Rectifier K+ Channel with Unique Pore Properties , 1998, Neuron.

[46]  F. Gage,et al.  In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector , 1996, Science.

[47]  M. Cour.  The retinal pigment epithelium controls the potassium activity in the subretinal space , 1985 .

[48]  C. Hamel,et al.  LEBER CONGENITAL AMAUROSIS WITH LARGE RETINAL PIGMENT CLUMPS CAUSED BY COMPOUND HETEROZYGOUS MUTATIONS IN KCNJ13 , 2017, Retinal cases & brief reports.

[49]  B. Hughes,et al.  Expression of Kir7.1 and a novel Kir7.1 splice variant in native human retinal pigment epithelium. , 2008, Experimental eye research.

[50]  M. la Cour.  The retinal pigment epithelium controls the potassium activity in the subretinal space. , 1985, Acta ophthalmologica. Supplement.